Towards an intellectual property bargaining theory: The post-wto Era

University of Pennsylvania Journal of International Economic Law

Volumn 32, Issue 1, 2010, Pages 265-368

  Benoliel, Daniel ^a   Salama, Bruno ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b FUNDAÇÃO GETÚLIO VARGAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959616047     PISSN: 10867872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (156)

1. Frederick M. Abbott, The WTO TRIPS Agreement and Global Economic Development, 72 CHI.-KENT L. REV. 385, (1996)
2. Rochelle Cooper Dreyfuss & Andreas F. Lowenfeld, Two Achievements of the Uruguay Round: Putting TRIPS and Dispute Settlement Together, 37 VA. J. INT'L L. (1997)
3. Arie Reich, From Diplomacy to Law: The Juridicization of International Trade Relations, 17 NW. J. INT'L L. & BUS. 775, 805 (1997)
4. Luciana Gross S. Cunha, Rule of Law and Development: The Discourses on Institutional Reforms in the Justice System (Artigos Direito GV, Working Paper No. 21, 2009), available at http://www.direitogv.com.br/interna.aspx?PagId= HTKCNKWI&IDCategory=26&IDSubCategory=146
5. Maria Dakolias, The Judicial Sector in Latin America and the Caribbean: Elements of Reform (World Bank, Technical Paper No. 319, 1996)
6. Robert J. Barro, Economic Growth in a Cross Section of Countries, 106 THE Q. J. OF ECON. 407 (1991)
7. F. M. Scherer & Jayashree Watal, Post- TRIPS Options for Access to Patented Medicines in Developing Countries 8-10 (World Health Org. Comm'n on Macroecon. & Health, Working Paper No. WG4: 1, 2001)
8. Mary Kopczynski, Robin Hood Versus the Bullies: Software Piracy and Developing Countries, 33 RUTGERS COMPUTER & TECH L.J. 299 (2007)
9. C.P. Chandrasekhar & Jayati Ghosh, WTO Drugs Deal: Does it Really Benefit Developing Countries?, THE HINDU BUS. LINE: INTERNET EDITION (Sept. 9, 2003), http://www.blonnet.com/2003/09/09/stories/2003090900140900.htm
10. WORLD HEALTH ORG. COMM'N ON MACROECON. AND HEALTH, HEALTH AND THE INTERNATIONAL ECONOMY 49 (2002)
11. MICHAEL E. PORTER, COMPETITIVE STRATEGY 108-22 (1980)
12. Frederick M. Abbott, Protecting First World Assets in the Third World: Intellectual Property Negotiations in the GATT Multilateral Framework, 22 VAND. J. TRANSNAT'L L. 689 (1989)
13. Richard H. Steinberg, Trade-Environment Negotiations in the EU, NAFTA, and the WTO: Regional Trajectories of Rule Development, 91 AM. J. INT'L L. 231, 233 (1997)
14. Carlos Morel et al., Health Innovation in Developing Countries to Address Diseases of the Poor, 1 INNOVATION STRATEGY TODAY 1, 2 (2005)
15. Shahid Yusuf, From Creativity to Innovation (World Bank, Working Paper No. 4262, 2007)
16. Overview of HIV and AIDS in India, AVERT, http://www.avert.org/aidsindia. htm (last visited Oct. 19, 2010)
17. HIV & AIDS in China, AVERT, http://www.avert.org/aidschina.htm (last visited Oct. 19, 2010) (describing the prevalence of AIDS in China).
18. Daniel R. Cahoy, Confronting Myths And Myopia on the Road from Doha, 42 GA. L. REV. 131, 172-192 (2007)
19. Free Software in Developing Countries Vital to Future Prosperity and Good Governance: UNU Technology Experts, UNITED NATIONS UNIV. (Mar. 15, 2006), http://www.unu.edu/media/archives/2006/files/mre-iist-3-06.pdf
20. Economic Partnership, Political Coordination and Cooperation Agreement between the European Community and its Member States, of the one part, and the United Mexican States, of the other part, Oct. 28, 2000, 2165 U.N.T.S. 111
21. Bryan Mercurio, TRIPS-Plus Provisions in FTAs: Recent Trends, in REGIONAL TRADE AGREEMENTS AND THE WTO LEGAL SYSTEM 215, 221 n.24 (Lorand Bartels & Federico Ortino eds., 2006)
22. Steve Hamm, Tech's Future, BUS. WK., Sept. 27, 2004, at 82
23. Carlos H. de Brito Cruz & Luiz de Mello, Boosting Innovation Performance in Brazil 5 (OECD Econ. Dep't, Working Paper No. 532, 2006)
24. ALAN WRIGHT, INNOVATION IN BRAZIL: PUBLIC POLICIES AND BUSINESS STRATEGIES (2008)
25. Brazil's AIDS Programme: A conflict of goals, ECONOMIST, May 12, 2007,
26. Ellen't Hoen, TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way from Seattle to Doha, 3 CHI. J. INT'L L. 27, 32 (2002)
27. Request for Consultations by Brazil, United States-US Patents Code, WT/DS224/1 (Feb. 7, 2001)
28. Celia W. Dugger, Brazil Overrides Merck Patent on AIDS Drug, N.Y. TIMES, May 5, 2007
29. Brazil Gets Abbott Discount, WALL ST. J., July 5, 2007, at B7.
30. Tove Iren S. Gerhardsen, Brazil Takes Steps to Import Cheaper AIDS Drug Under Trade Law, INTELLECTUAL PROP. WATCH, May 7, 2007, http://www.ipwatch.org/ weblog/index.php?p=614&res=1280&print=0
31. OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE, 2007 SPECIAL 301 REPORT, 30, available at http://www.ustr.gov/sites/default/files/asset-upload- file230-11122.pdf
32. Richard Walker, Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for STOCRIN™, AIDSPORTAL, May 4, 2007, http://www.aidsportal.org/news-details.aspx?ID=4635
33. R.A. Malshekar, Dir. General, Council of Sci. and Indus. Research, Speech at 10th Zuckerman Lecture (June 11, 2003).
34. CENTRAL BANK OF BRAZIL, INVESTIMENTO ESTRANGEIRO DIRETO (2008)
35. BANCO CENTRAL DO BRASIL, DISTRIBUíÇÃO POR ATIVIDADE ECONÓMICA DE APLICAÇÃO DOS RECURSOS (2007) .
36. Member States Agree to Further Examine Proposal on Development, WORLD INTELLECTUAL PROP. ORG., Oct. 4, 2004, http://www.wipo.int/pressroom/en/html. jsp?file=/redocs/prdocs/en/2004/wipo-pr-2004-396.html
37. Member States Adopt a Development Agenda for WIPO, WORLD INTELLECTUAL PROP. ORG. (Oct. 1, 2007), www.wipo.int/pressroom/en/articles/2007/article-0071. html
38. Brian Fitzgerald & Nic Suzor, Legal Issues for the Use of Free and Open Source Software in Government, 29 MELB. U. L. REV. 412, 422 (2005)
39. Daniel F. Olejko, Comment, Charming a Snake: Open Source Strategies for Developing Countries Disillusioned with TRIPs, 25 PENN ST. INT'L L. REV. 855, 858 (2007)
40. Todd Benson, Brazil: Free Software's Biggest and Best Friend, N.Y. TIMES, March 29, 2005, http://www.nytimes.com/2005/03/29/technology/29computer.html.
41. Brazil Gives Nod to Open Source, WIRED, Nov. 16, 2003, http://www.wired.com/techbiz/it/news/2003/11/61257
42. SANJIVA WEERAWARANA & JIVAKA WEERATUNGA, OPEN SOURCE IN DEVELOPING COUNTRIES 30 (2004), available at http://www.eldis.org/fulltext/opensource.pdf
43. G-20, WHAT IS THE G-20, http://www.g20.org/about-what-is-g20.aspx (last visited Oct. 23, 2010)
44. Pablo A. Ormachea, Agriculture Subsidies and the Free Trade Area of the Americas, 13 LAW & BUS. REV. AM. 139, 149 (2007)
45. Press Release, World Intellectual Prop. Org., Member States Agree to Further Examine Proposal on Development, WIPO/PR/2004/396 (Oct. 4, 2004), available at www.wipo.int/edocs/prdocs/en/2004/wipo-pr-2004-396.html
46. Press Release, World Intellectual Prop. Org., Member States Adopt a Development Agenda for WIPO, WIPO/PR/2007/521 (Oct. 1, 2007), available at www.wipo.int/pressroom/en/articles/2007/article-0071.html
47. ANDRéANNE LéGER, THE ROLE(S) OF INTELLECTUAL PROPERTY RIGHTS FOR INNOVATION: A REVIEW OF THE EMPIRICAL EVIDENCE AND IMPLICATIONS FOR DEVELOPING COUNTRIES 10 (2007), available at http://www.diw.de/documents/ publikationen/73/61916/dp707.pdf
48. Colleen Chien, Cheap Drugs at What Price to Innovation: Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation?, 18 BERKELEY TECH. L.J. 853, 856 (2003)
49. DOUGLAS LIPPOLDT, INTELLECTUAL PROPERTY RIGHTS, PHARMACEUTICALS AND FOREIGN DIRECT INVESTMENT 7 (2005), available at http://www.gem.sciencespo.fr/ content/publications/pdf/lippoldt-IPRs-Pharma-FDI1106.pdf.
50. Frederick Noronha, Developing Countries Gain from Free/Open-Source Software, LINUX J., May 20, 2003, http://www.linuxjournal.com/article/6884
51. Editorial, Bangkok's Drug War Goes Global, WALL ST. J. EUR., Mar. 7, 2007
52. Ronald A. Cass, Thai Patent Turmoil, WALL ST J. ASIA, Mar. 13, 2007, at 13
53. Tove Iren S. Gerhardsen, Drug Company Reacts to Thai License; Government Ready to Talk, INTELLECTUAL PROP. WATCH (Feb. 16, 2007), http://www.ip-watch. org/weblog/index.php?p=538&res=1280&print=0
54. Sanchai Chasombat et al., The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand, 37 SOUTHEAST ASIAN J. TROPICAL MED. & PUB. HEALTH 704, 706 (2006)
55. AMES GROSS, NEW REGULATORY TRENDS IN THAILAND'S PHARMACEUTICAL MARKET (1999), available at http://www.pacificbridgemedical.com/publications/html/ ThailandMar1999.htm
56. Press Release, Research and Mkts., In Thailand's Pharmaceutical Market Generics Are Likely to Be the Fastest-Growing Segment, Reaching US$1.63bn in from US$1.1bn in 2005, (May 1, 2007), available at http://findarticles.com/p/articles/mi-m0EIN/is-2007-May-1/ai-n27219824.
57. Press Release, Médecins sans Frontières, MSF Denounces Abbott's Move to Withhold Medicines from People in Thailand (Mar. 15, 2007), available at http://www.msf.org/msfinternational/invoke.cfm?objectid=55646135- 15C5-F00A-25D3DAC13D288586&component=toolkit.pressrelease&method= full-html
58. Nicholas Zamiska, Abbott's Thai Pact May Augur Pricing Shift, WALL ST. J., Apr. 23, 2007, at A3
59. Henry J. Kaiser Family Foundation, Abbott To Stop Launching New Drugs in Thailand in Response to Country's Compulsory License for Antiretroviral Kaletra, KAISER DAILY HIV/AIDS REPORT (Mar. 14, 2007), http://www .kaisernetwork.org/ daily-reports/rep-index.cfm?hint=1&DR-ID=43558
60. Sanya Smith, Thai Human Rights Commission Criticizes FTA with US, THIRD WORLD NETWORK, Jan. 26, 2007, http://www.twnside.org.sg/title2 /twninfo492.htm
61. Human Rights Watch - HIV/AIDS Program, Comment on the Draft Text of the Agreement on the Free Trade Area of the Americas (2003), available at http://www.cptech.org/ip/ftaa/hrw02272003.html
62. WORLD HEALTH ORG. & UNAIDS, PROGRESS ON GLOBAL ACCESS TO HIV ANTIRETROVIRAL THERAPY: A REPORT ON "3 BY 5" AND BEYOND 36 (2006)
63. Nathan Ford et al., Sustaining Access to Antiretroviral Therapy in the Less- Developed World: Lessons from Brazil and Thailand, 21 AIDS S21, S21 (2007)
64. CHERI GRACE, THE EFFECT OF CHANGING INTELLECTUAL PROPERTY ON PHARMACEUTICAL INDUSTRY PROSPECTS IN INDIA AND CHINA: CONSIDERATIONS FOR ACCESS TO MEDICINE 15 (2004)
65. HIV and AIDS in Brazil, AVERT, http://www.avert.org/aids-brazil.htm (last visited Oct. 23, 2010)
66. HIV and AIDS in China, AVERT, http://www.avert.org/aidschina.htm (last visited Oct. 23, 2010)
67. HIV and AIDS in India, AVERT, http://www.avert.org/aidsindia.htm (last visited Oct. 23, 2010)
68. HIV and AIDS in Thailand, AVERT, http://www.avert.org /aidsthai.htm (last visited Oct. 23, 2010)
69. Jim O'Neill et al., Global Economics Paper No.134: How Solid Are the BRICs?, GOLDMAN SACHS ECON. RES., Dec. 2005, at 1, 19 app.3, available at http://www2.goldmansachs.com/ideas/brics/how-solid-doc.pdf.
70. Sonia E. Rolland, Developing Country Coalitions at the WTO: In Search of Legal Support, 48 HARV. INT'L L.J. 483, 496 (2007)
71. Ruth Mayne, The Global Campaign on Patents and Access to Medicines: An Oxfam Perspective, in GLOBAL INTELLECTUAL PROPERTY RIGHTS: KNOWLEDGE, ACCESS AND DEVELOPMENT 244, 249 (Peter Drahos & Ruth Mayne eds., 2002)
72. SUSAN K. SELL, PRIVATE POWER, PUBLIC LAW: THE GLOBALIZATION OF INTELLECTUAL PROPERTY RIGHTS 146, 181 (2003)
73. Philippe Cullet, The Doha Declaration of the WTO and Access to Medicines (Int'l Envtl. Law Research Ctr., Briefing Paper No. 2002-1, 2002), available at http://www.ielrc.org/content/f0201.htm
74. Mary Beth Walker, Assessing the Barriers to Universal Antiretroviral Treatment Access for HIV/AIDS in South Africa, 15 DUKE J. COMP. & INT'L L. 193, 210 (2004)
75. Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, Pub. L. No. 105-277 , 112 Stat. 2681-26155 (1999)
76. JAMES LOVE, FIVE COMMON MISTAKES BY REPORTERS COVERING US/SOUTH AFRICA DISPUTES OVER COMPULSORY LICENSING AND PARALLEL IMPORTS, http://www.cptech.org/ ip/health/sa/mistakes.html (last visited Oct. 23, 2010)
77. EUROPEAN COMMISSION, DIFFERENT NEEDS, DIFFERENT RESPONSIBILITIES: WHAT IS THE EU ASKING FROM DEVELOPING COUNTRIES?, http://trade.ec.europa.eu/doclib/ docs/2005/december/tradoc-126493.pdf (last visited Oct. 23, 2010)
78. C. S. Srinivasan & Colin Thirtle, Impact of Terminator Technologies, in Developing Countries: A Framework for Economic Analysis, in ECONOMIC AND SOCIAL ISSUES IN AGRICULTURAL BIOTECHNOLOGY 159, 161
79. John Vidal, World Braced for Terminator 2, GUARDIAN., Oct. 6, 1999, at 14, available at http://www.guardian.co.uk/science/1999/oct/06/gm.food2.
80. Press Release, Rural Advancement Found. Int'l Biodiversity Convention's Terminator Decision Fails Biodiversity and Fails Farmers (June 28, 1999), available at http://www.cbd.int/doc/meetings/sbstta/sbstta-09/information/ sbstta-09-inf-06-en.pdf
81. DESCRIPTION OF THE IIPA, http://www.iipa.com/aboutiipa.html (last visited Oct. 23, 2010)
82. MEMBER ASSOCIATIONS, http://www.iipa.com/memberassociations.html (last visited Oct. 23, 2010)
83. ROBYN MEREDITH, THE ELEPHANT AND THE DRAGON: THE RISE OF INDIA AND CHINA AND WHAT IT MEANS FOR ALL OF US 63 (2007)
84. JAIRAM RAMESH, MAKING SENSE OF CHINDIA: REFLECTIONS ON CHINA AND INDIA (2006)
85. Shubham Chaudhuri & Martin Ravallion, Partially Awakened Giants: Uneven Growth in China and India, in DANCING WITH GIANTS: CHINA, INDIA, AND THE GLOBAL ECONOMY 175 (L. Alan Winters & Shahid Yusuf eds., 2007)
86. Daniel C.K. Chow, Why China Does Not Take Commercial Piracy Seriously, 32 OHIO N.U. L. REV. 203, 208 (2006)
87. Dominic Wilson & Roopa Purushothaman, Global Economics Paper No. 99: Dreaming with BRICs: The Path to 2050, GOLDMAN SACHS ECON. RES., Oct. 2003, at 4, available at http://www2.goldmansachs.com/ideas/brics/book/99-dreaming.pdf
88. Nicholas D. Kristof, They're Rounding the First Turn! And the Favorite Is. N.Y. TIMES, Jan. 17, 2006, at A19
89. Janice M. Mueller, The Tiger Awakens: The Tumultuous Transformation of India's Patent System and the Rise of Indian Pharmaceutical Innovation, 68 U. PITT. L. REV. 491, 503 (2007)
90. Jeffrey A. Andrews, Pfizer's Viagra Patent and the Promise of Patent Protection in China, 28 LOY. L.A. INT'L & COMP. L. REV. 1 (2006)
91. Ke Shao, Look at My Sign!-Trademarks in China from Antiquity to the Early Modern Times, 87 J. PAT. & TRADEMARK OFF. SOC'Y 654 (2005)
92. Robert Slate, Judicial Copyright Enforcement in China: Shaping World Opinion on TRIPS Compliance, 31 N.C. J. INT'L L. & COM. REG. 665 (2006)
93. V. C. Vivekanandan, HRD Intellectual Prop. Chair Professor, Nalsar Univ. of Law, Post TRIP: Emerging issues for Pharma Industry (July 11, 2008), available at http://pharmexcil.com/data/uploads/Prof.Vivekanandan.ppt
94. Jaya Prakash Pradhan, Overcoming Innovation Limits through Outward FDI: The Overseas Acquisition Strategy of Indian Pharmaceutical Firms, INSTITUTE FOR THE STUDY OF INDUSTRIAL DEVELOPMENT, July 2008, available at MPRA, Paper No. 12362, http://mpra.ub.uni-muenchen.de/12362/1/MPRA0-paper-12362.pdf
95. Cheri Grace, The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China: Considerations for Access to Medicines 18 (DFID-Health Systems Resource Centre, 2004)
96. Christoph Antons, Sui Generis Protection for Plant Varieties and Traditional Agricultural Knowledge: The Example of India, 29 EUR. INTELL. PROP. REV. 480, 480 (2007).
97. Intel Plans $1bn India Investment, BBC NEWS (Dec. 5, 2005), available at http://news.bbc.co.uk/2/hi/business/4499362.stm
98. BUS. SOFTWARE ALLIANCE & INT'L DATA CORP., SECOND ANNUAL BSA AND IDC GLOBAL SOFTWARE PIRACY STUDY 3 (2005).
99. Maria Nelson et al., Counterfeit Pharmaceuticals: A Worldwide Problem, 96 TRADEMARK REP. 1068, 1089 (2006)
100. Fang Xin, Member of Standing Committee, NPC, China, From Imitation to Innovation: A Strategic Adjustment in China's S&T Development, Seminar on Latin American, Caribbean, and Asian Strategies for Science, Technology, and Competitiveness (Apr. 7, 2005), http://info.worldbank.org/etools/docs/library/ 152771/Dr-Fang.pdf
101. Technology in Emerging Economies, ECONOMIST, Feb. 9, 2008, at 75.
102. Gary H. Jefferson, R&D and Innovation in China: Has China Begun Its S&T Takeoff? (Aug. 11, 2004) (unpublished manuscript) available at http://people.brandeis.edu/~jefferso/HCR,%20August%2011,%2004a.pdf
103. Huaiwen He & Ping Zhang, Impact of the Intellectual Property System on Economic Growth, WIPO-JPO-UNU Joint Research Project 7 (2007), available at http://www.wipo.int/about-ip/en/studies/pdf/wipo-unu-07-china.pdf
104. A.T. Kearney, New Concerns in an Uncertain World: The 2007 A.T. Kearney Foreign Direct Investment Confidence Index, THE GLOBAL BUS. POL'Y COUNCIL (2008), available at http://www.atkearney.com/images/global/pdf/FDICI-2007.pdf
105. Peter K. Yu, International Enclosure, the Regime Complex, and Intellectual Property Schizophrenia, 2007 MICH. ST. L. REV. 1, 25-26 (2007)
106. Least-Developed Countries, WORLD TRADE ORG., http://www.wto.org/english/ theWTO-e/whatis-e/tif-e/org7-e.htm
107. U.N. OFFICE OF THE HIGH REPRESENTATIVE FOR THE LEAST DEV. COUNTRIES, THE LEAST DEVELOPED COUNTRIES: THINGS TO KNOW, THINGS TO DO 1, 2 (2009), http://www.unohrlls.org/UserFiles/File/LDC%20Documents/Advocacy %20brochure%20english%20for%20web.pdf
108. Andrew T. Guzman, Why LDCs Sign Treaties that Hurt Them: Explaining the Popularity of Bilateral Investment Treaties, 38 VA. J. INT'L L. 639, 648 (1998)
109. Texaco Overseas Petroleum Co. v. Libya, 17 I.L.M. 1, 30 (Int'l Arbitral Trib. 1978)
110. Understanding the WTO: Developing Countries, WORLD TRADE ORG., http://www.wto.org/english/thewto-e/whatis-e/tif-e/dev1-e.htm (last visited Aug. 25, 2009)
111. Simon Lester, The Asian Newly Industrialized Countries to Graduate From Europe's GSP Tariffs, 36 HARV. INT'L L.J. 220, 230 (1995)
112. David A. Lax and James K. Sebenius, Interests: The Measure of Negotiation in NEGOTIATION THEORY AND PRACTICE 165 (J. William Breslin & Jeffrey Z. Rubin eds., 1991).
113. JONATHAN SACKS, THE POLITICS OF HOPE 198-09 (1997)
114. ROBERT AXELROD, THE EVOLUTION OF COOPERATION 3-24 (1984)
115. ROGER FISHER & WILLIAM URY, GETTING TO YES: NEGOTIATING AGREEMENT WITHOUT GIVING IN 4-5 (2d ed. 1981)
116. Ruth L. Gana, The Myth of Development, The Progress of Rights: Human Rights to Intellectual Property and Development, 18 LAW & POL'Y 315, 334 (1996)
117. Donald P. Harris, Carrying a Good Joke Too Far: TRIPS and Treaties of Adhesion, 27 U. PA. J. INT'L ECON. L. 681, 724-25 (2006)
118. Chetan Gulati, Note, The "Tragedy of The Commons" in Plant Genetic Resources: The Need for a New International Regime Centered Around an International Biotechnology Patent Office, 4 YALE HUM. RTS. & DEV. L.J. 63, 63-64 (2001)
119. Bongo Adi, Intellectual Property Rights in Biotechnology and the Fate of Poor Farmers' Agriculture, 9 J. WORLD INTELL. PROP. 91, 104-07 (2006)
120. Chidi Oguamanam, Genetic Use Restriction (or Terminator) Technologies (GURTs) in Agricultural Biotechnology: The Limits of Technological Alternatives to Intellectual Property, 4 CAN. J.L. & TECH. 59, 60-62 (2005)
121. Arie Reich, The WTO As a Law-Harmonizing Institution, 25 U. PA. J. INT'L ECON. L. 321, 362 (2004)
122. Gregory Shaffer, Power, Governance, and the WTO: A Comparative Institutional Approach, in POWER IN GLOBAL GOVERNANCE 130, 130 (Michael Barnett & Raymond Duvall eds., 2005)
123. Abhinay Muthoo, On the Strategic Role of Outside Options in Bilateral Bargaining, 43 OPERATIONS RES. 292 (1995)
124. Letter from U.N. Special Envoys for HIV/AIDS to the Prime Minister and President of India, Amendments to the Patents Act Under Debate (Mar. 11, 2005), www.cptech.org/ip/health/c/india/unaids03112005.html
125. Achmat Dangor, Director of Advocacy, Commc'n and Leadership for UNAIDS, to Kamal Nath, Minister of Commerce and Indus. of India (Feb. 23, 2005), www.cptech.org/ip/health/c/india/unaids02232005.html (last visited Aug. 25. 2009)
126. Hulya Ulku, R&D, Innovation, and Economic Growth: An Empirical Analysis (Int'l Monetary Fund, Working Paper No. WP/04/185, Sept. 2004), available at http://imf.org/external/pubs/ft/wp/2004/wp04185.pdf
127. WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases, WORLD HEALTH ORG. (2000), available at http://www.who.int/csr/resources/CSR-ISR- 2000-1hiv/en (discussing how HIV/AIDS mutates).
128. Randeep Ramesh, Cheap AIDS Drugs Under Threat, THE GUARDIAN (UK), Mar. 23, 2005
129. Letter from U.N. Special Envoys for HIV/AIDS, to the Prime Minister and President of India, On the Amendments to the Patents Act Under Debate (Mar. 11, 2005), www.cptech.org/ip/health/c/india /unaids03112005.html (last visited Oct. 15, 2010)
130. Understanding The WTO: The Agreements, Intellectual Property: Protection And Enforcement, WORLD TRADE ORG., www.wto.org/english/thewto-e/whatis-e/tif-e/ agrm7-e.htm (last visited Aug. 25, 2009)
131. Amir Attaran & Lee Gillespie-White, Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?, 286 J. AM. MED. ASS'N. 1886, 1886-1906 (2001)
132. Srividhya Ragavan, The Jekyll and Hyde Story of International Trade: The Supreme Court in PhRMA v. Walsh and the TRIPS Agreement, 38 U. RICH. L. REV. 777 (2004)
133. World Trade Organization, Amendment of the TRIPS Agreement, Dec. 8, 2005, WT/L/641
134. World Trade Organization, Ministerial Declaration on the TRIPS Agreement and Public Health, 6, WT/MIN(01)/DEC/2, 41 I.L.M. 755 (2002)
135. Peter K. Yu, The International Enclosure Movement, 82 IND. L.J. 827, 848 (2007)
136. Frederick M. Abbott & Jerome H. Reichman, The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines Under the Amended TRIPS Provisions, 10 J. INT'L ECON. L. 921, 973-77 (2007)
137. SISULE F. MUSUNGU ET AL., UTILIZING TRIPS FLEXIBILITIES FOR PUBLIC HEALTH PROTECTION THROUGH SOUTH-SOUTH REGIONAL FRAMEWORK xv-xvi (South Centre 2004)
138. Jeffrey Sparshott, U.S. Refusal Thwarts WTO Drug-Patent Talks - Bush Seeks Supporters of Interim Plan to Ease Enforcement for Poor Nations, WASH. TIMES, Dec. 25, 2002, at C10.
139. Editorial, A Global Medicine Deal, N.Y. TIMES, Jan. 5, 2003
140. Joan Rovira, Creating and Promoting Domestic Drug Manufacturing Capacities: A Solution for Developing Countries, in Negotiating Health in Negotiating Health, NEGOTIATING HEALTH: INTELLECTUAL PROPERTY AND ACCESS TO MEDICINES 227, 235 (2006).
141. Frederick M. Abbott, The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health, 99 AM. J. INT'L L. 317, 334 (2005)
142. Rajesh Gupta et al., Responding to Market Failures in Tuberculosis Control, SCI. 1049, 1049 (2001)
143. Karen Zwi et al., Cheaper Antiretrovirals to Treat AIDS in South Africa: They are at Their Most Cost Effective in Preventing Mother to Child Transmission, 320 BRIT. MED. J. 1551, 1551 (2000)
144. William A. Lovett, Current World Trade Agenda: GATT, Regionalism, and Unresolved Asymmetry Problems, 62 FORDHAM L. REV. 2001, 2006 (1994).
145. Jagdish Bhagwati, Aggressive Unilateralism: An Overview, in AGGRESSIVE UNILATERALISM: AMERICA'S 301 TRADE POLICY AND THE WORLD TRADING SYSTEM 1-4 (Jagdish Bhagwati & Hugh T. Patrick eds., 1990)
146. "Price-takers" is a financial term describing parties who are forced to accept whatever price the market sets, and lack the ability to affect or shift the market price. EDNA CAREW, THE LANGUAGE OF MONEY 3, at 260-61 (1996).
147. John Macdonald, The Top Ten and Emerging Pharmaceutical Markets, BUSINESS INSIGHTS, available at http://www.globalbusinessinsights.com/content/rbhc0018m. pdf (last visited, October 21, 2010).
148. Frederick M. Abbott, The Enduring Enigma of TRIPs: A Challenge for the World Economic System, 1 J. INT'L ECON. L. 497, 521 (1998)
149. Rebecca S. Eisenberg, Bargaining over the Transfer of Proprietary Research Tools: Is This Market Failing or Emerging?, in EXPANDING THE BOUNDARIES OF INTELLECTUAL PROPERTY: INNOVATION POLICY FOR THE KNOWLEDGE SOCIETY 223 (Rochelle Dreyfuss et al. eds., 2001)
150. Joseph E. Stiglitz, Knowledge as a Global Public Good, in GLOBAL PUBLIC GOODS: INTERNATIONAL COOPERATION IN THE 21ST CENTURY 308, 311 (Inge Kaul et al. eds., 1999)
151. Gideon Parchomovsky & Peter Siegelman, Towards an Integrated Theory of Intellectual Property, 88 VA. L. REV. 1455, 1458-60 (2002).
152. Carlos M. Correa, Managing the Provision of Knowledge: The Design of Intellectual Property Laws, in PROVIDING GLOBAL PUBLIC GOODS: MANAGING GLOBALIZATION 410, 414 (Inge Kaul et al. eds., 2003).
153. Claudia Chamas et al., Current Issues of IP Management in Health and Agriculture in Brazil, in INTELLECTUAL PROPERTY MANAGEMENT IN HEALTH AND AGRICULTURAL INNOVATION: A HANDBOOK OF BEST PRACTICES 1563 (Anatole Krattiger et al. eds., 2007)
154. Michael S. Mireles, The Bayh-Dole Act and Incentives for the Commercialization of Government-Funded Invention in Developing Countries, 76 UMKC L. REV. 525, (2007)
155. Chris Bull, Managing Intellectual Assets at Universities: The South African Government is Considering the Introduction of Legislation Similar to the US Bayh-Dole Act Governing Intellectual Property Arising from University R&D, MANAGING INTELL. PROP. (Apr. 1, 2005), available at http://business.highbeam.com/435489/article- 1G1-132162379/managing- intellectual-assets-universities-south-african
156. Should SA Follow US Lead on Patent Laws?, AFRICA NEWS, Jan. 13, 2004